Miracle Mile Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Miracle Mile Advisors's RGEN Position: Q1 2022 in Review
Miracle Mile Advisors sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,050 shares — an estimated $278K sold.
Miracle Mile Advisors first reported a position in RGEN in Q4 2020 and held it in 5 quarters. The position peaked at $312K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- Miracle Mile Advisors reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- Miracle Mile Advisors sold 1,050 Repligen shares in Q1 2022, an estimated $278K.
- Miracle Mile Advisors first reported a position in Repligen in Q4 2020 and held it in 5 quarters.
- Miracle Mile Advisors's Repligen position peaked at $312K in Q3 2021.
- 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on Miracle Mile Advisors's 13F filing for Q1 2022, filed 25 Apr 2022.